Five Reasons to implement LC-MS platforms for your laboratory developed tests
Implementing LC-MS requires sufficient justification and commitment of resources but can have a very positive impact on clinical and business goals.
contributed by Thermo Fisher Scientific |
Technological advancements in Liquid Chromatography (LC) coupled to Mass Spectrometry (MS) technology, especially in the last decade, have opened several options to leverage this technology in the clinical diagnostic laboratory arena. Hence, from the analysis of acylcarnitines and amino acids in neonatal blood spots during the early 90s, LC-MS technology is now being used for other applications, such as endocrinology, toxicology, pharmacology, and therapeutic drug monitoring. However, it is still far from being considered as the “first choice” when it comes to deciding the technology for laboratory developed tests (LDTs).
Read the full article now
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.